Medpace Holdings, Inc. 從事向生物技術、製藥和醫療器械行業提供外包臨床開發服務。公司總部位於俄亥俄州辛辛那提,目前擁有5,900名全職員工。公司於2016年8月11日上市。該公司與製藥、生物技術和醫療器械公司合作,協助進行臨床試驗的開發與執行。該公司的藥物開發服務主要集中在全服務的第I至第IV期臨床開發服務,包括開發計劃設計、協調中央實驗室、項目管理、法規事務、臨床監測、數據管理和分析、藥物警戒新藥申請提交以及上市後臨床支持。該公司還提供生物分析實驗室服務、臨床人體藥理學、影像服務以及為臨床試驗提供心電圖讀取支持。公司的業務主要分佈在北美、歐洲和亞洲。
Dr. August Troendle is the Chairman of the Board of Medpace Holdings Inc, joining the firm since 1992.
What is the price performance of MEDP stock?
The current price of MEDP is $0, it has 下降 0% in the last trading day.
What are the primary business themes or industries for Medpace Holdings Inc?
Medpace Holdings Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Medpace Holdings Inc market cap?
Medpace Holdings Inc's current market cap is $NaN
Is Medpace Holdings Inc a buy, sell, or hold?
According to wall street analysts, 15 analysts have made analyst ratings for Medpace Holdings Inc, including 0 strong buy, 1 buy, 11 hold, 4 sell, and 0 strong sell